More cancer patients surviving for longer
October 31, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, bladder, breast, myeloma, oncology, ons, prostate
Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …
Carmago hires drug development head
October 31, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing carmago, steven castillo
US drug development firm Camargo Pharmaceutical Services has expanded its leadership team with the appointment of Steven Castillo as vice …
Microsoft enters into wearables market
October 30, 2014Medical Communications, Sales and Marketing Apple, Microsoft, band, fitness, health, watch, wearable, wearables
Microsoft has launched a new wearable heath tracking device as it looks to battle with Apple and Samsung in an …
Two neuroscientists join Biogen Idec
October 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biogen IDEC, richard ransohoff
Christopher Henderson and Richard Ransohoff have joined Biogen Idec to lead the company’s neurology research and discovery efforts. Henderson joins …
Takeda and Lilly get Actos trial reprieve
October 29, 2014Sales and Marketing Actos, Takeda, bladder cancer, diabetes, lilly
A judge has dramatically reduced the $9 billion damages bill Takeda and Lilly were set to pay over safety allegations …
Sovaldi misses estimates but still makes history
October 29, 2014Research and Development, Sales and Marketing FDA, Gilead, harvoni, hep C, sofosbuvir, sovaldi
The trajectory of Gilead’s new hep C pill Sovaldi has slowed but the drug is still on course to break …
Sanofi’s chief executive ousted
October 29, 2014Medical Communications, Research and Development, Sales and Marketing Christopher Viehbacher, Sanofi
Sanofi’s chief executive Chris Viehbacher has been ejected from his role after the French firm’s board lost patience with his …
Google X developing diagnosis pill
October 29, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables
Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …
Cancer Drugs Fund ‘papering over the cracks of a bigger issue’
October 29, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform
Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …
Quantum promotes senior head
October 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alison Doering, quantam pharmaceutical
Alison Doering has been promoted to head of group marketing and communications at medicines manufacturing firm Quantum Pharmaceutical. Doering will …
PrimeVigilance Limited upgrades its validated databases for pharmacovigilance and medical information – ARISg™ and agInquirer™.
October 28, 2014PrimeVigilance Limited, a pharmaceutical service provider for Pharmacovigilance and Medical Information operations today announced the completion of a major upgrade …
Merck revenue falls
October 28, 2014Manufacturing and Production, Sales and Marketing Frazier, Merck, Q3, Victrelis, hep C, sovaldi
Merck has posted a set of disappointing financials for the latest quarter as it cuts cost across its business to …
Karus Therapeutics appoints two heads
October 28, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Peter Finan, Simon Roitt, karus
UK drug development firm Karus Therapeutics has grown its R&D team via two new appointments in Dr Simon Roitt, who …
Celgene expands immunotherapy pipeline with Sutro
October 27, 2014Research and Development, Sales and Marketing Celgene, PD-1 and PD-L1, Q3, oncology, sutro
Celgene has extended its collaboration with Sutro Biopharma and added a buyout option for the firm as the two companies …
AZ oncology drug a ‘Phoenix from the flames’
October 27, 2014Sales and Marketing AstraZeneca, CHMP, EC, lynparza, olaparib, oncology
As the possibility of a deal with Pfizer fades, AstraZeneca is continuing its argument for independence as a key cancer …
Scenesse recommended for rare sun disease in Europe
October 27, 2014Sales and Marketing CHMP, Clinuvel Pharmaceuticals, EMA, EU, scenesse
The European Medicines Agency is recommending that Scenesse (afamelanotide) be approved for the prevention of severe sun burn in adults …
France Focus: Power without responsibility?
October 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report
Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: François Hollande of the centre-left Socialist Party Gross Domestic Product: …
Cubist Pharmaceuticals names chief executive
October 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cubist, perez
US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …
Cancer drug discovery system ‘broken’
October 24, 2014Research and Development, Sales and Marketing Cancer, cancer research, oncology, paul workman
The global system for discovering new cancer drugs is ‘broken’ and failing to turn scientific advances into enough innovative new …
Lacklustre sales hit Lilly again
October 24, 2014Sales and Marketing Q3, cymbalta, humilin, lilly, sales, zyprexa
Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
